Residual Effects of Sleep Medications Are Commonly Reported and Associated with Impaired Patient-Reported Outcomes among Insomnia Patients in the United States
Sleep Disorders · 2015 · 2015 · 1-9
DOI: 10.1155/2015/607148 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sleep Disorders, 2015. Verfasst von Timothy Fitzgerald und 1 weiteren Autor:innen. Beteiligte Einrichtung: Merck & Co., Whitehouse Station, NJ 08889, USA. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Merck & Co..
Themen: Schlaf
Abstract (Originalsprache)
Study Objective . To measure the association of symptoms attributed to residual effects of sleep medication (e.g., drowsiness, difficulty concentrating, and impaired memory) on self-reported functioning and satisfaction with these medications.
Methods
Individuals using prescription medications for insomnia were invited to complete an Internet-based survey. Respondents were compared according to the presence of self-reported residual effects; relationships between severity of these effects and outcomes were modeled using regression. Measures included the Brief Insomnia Questionnaire, Work Productivity and Activity Impairment Questionnaire, and SATMED-Q. Subgroup analyses were conducted with patients aged ≥65 years. Approximately 80% reported experiencing ≥1 residual effect. The severity of residual effects was associated with increased residual effect-related work impairment, including absenteeism (RR = 1.46, p < 0.001 ), presenteeism (RR = 1.12, p < 0.001 ), overall work impairment (RR = 1.13, p < 0.001 ), and nonwork activity impairment (RR = 1.11, p < 0.001 ). More severe residual symptoms were also associated with increased difficulty in home management (Beta = .31, p < 0.001 ), ability to work (Beta = .31, p < 0.001 ), social relationships, (Beta = .32, p < 0.001 ), close personal relationships (Beta = .30, p < 0.001 ), and lower medication satisfaction (Beta = - . 37 , p < 0.001 ).
Conclusions
Individuals using medications for insomnia commonly experience symptoms considered as residual effects, and these symptoms are associated with greater interference of sleep-related problems at work, at home, and with social relationships.
Autor:innen und Institutionen
- Merck & Co., Whitehouse Station, NJ 08889, USA.
- Kantar Health, 20121 Milan, Italy.
Förderung
- Merck & Co.
Zitieren
APA
Fitzgerald, T., & Vietri, J. (2015). Residual Effects of Sleep Medications Are Commonly Reported and Associated with Impaired Patient-Reported Outcomes among Insomnia Patients in the United States. Sleep Disorders, 2015, 1-9. https://doi.org/10.1155/2015/607148
Vancouver
Fitzgerald T, Vietri J. Residual Effects of Sleep Medications Are Commonly Reported and Associated with Impaired Patient-Reported Outcomes among Insomnia Patients in the United States. Sleep Disorders. 2015;2015:1-9. doi:10.1155/2015/607148
BibTeX
@article{Fitzgerald2015,
author = {Fitzgerald, Timothy and Vietri, Jeffrey},
title = {Residual Effects of Sleep Medications Are Commonly Reported and Associated with Impaired Patient-Reported Outcomes among Insomnia Patients in the United States},
journal = {Sleep Disorders},
year = {2015},
volume = {2015},
pages = {1--9},
doi = {10.1155/2015/607148}
}
EUVIMED